32 Works

Additional file 2 of Successful breastfeeding following a level II NICU stay in Qatar – a longitudinal study

Brijroy Viswanathan, Rajai El Bedaywi, Ahmed Tomerak, Sarfrazul Abedin & Prem Chandra
Additional file 2. Questionnaire.

sj-docx-2-opp-10.1177_10781552231160275 - Supplemental material for Cost savings and cost avoidance with the inpatient clinical pharmacist interventions in a tertiary cancer care hospital

Dina Abushanab, Amaal Gulied, Anas Hamad, Mohammad Abu-Tineh, Palli V Abdul Rouf, Moza Al Hail, Wessam El-Kassem, Maguy S El Hajj & Daoud Al-Badriyeh
Supplemental material, sj-docx-2-opp-10.1177_10781552231160275 for Cost savings and cost avoidance with the inpatient clinical pharmacist interventions in a tertiary cancer care hospital by Dina Abushanab, Amaal Gulied, Anas Hamad, Mohammad Abu-Tineh, Palli V Abdul Rouf, Moza Al Hail, Wessam El-Kassem, Maguy S El Hajj and Daoud Al-Badriyeh in Journal of Oncology Pharmacy Practice

sj-docx-2-opp-10.1177_10781552231160275 - Supplemental material for Cost savings and cost avoidance with the inpatient clinical pharmacist interventions in a tertiary cancer care hospital

Dina Abushanab, Amaal Gulied, Anas Hamad, Mohammad Abu-Tineh, Palli V Abdul Rouf, Moza Al Hail, Wessam El-Kassem, Maguy S El Hajj & Daoud Al-Badriyeh
Supplemental material, sj-docx-2-opp-10.1177_10781552231160275 for Cost savings and cost avoidance with the inpatient clinical pharmacist interventions in a tertiary cancer care hospital by Dina Abushanab, Amaal Gulied, Anas Hamad, Mohammad Abu-Tineh, Palli V Abdul Rouf, Moza Al Hail, Wessam El-Kassem, Maguy S El Hajj and Daoud Al-Badriyeh in Journal of Oncology Pharmacy Practice

sj-docx-3-opp-10.1177_10781552231160275 - Supplemental material for Cost savings and cost avoidance with the inpatient clinical pharmacist interventions in a tertiary cancer care hospital

Dina Abushanab, Amaal Gulied, Anas Hamad, Mohammad Abu-Tineh, Palli V Abdul Rouf, Moza Al Hail, Wessam El-Kassem, Maguy S El Hajj & Daoud Al-Badriyeh
Supplemental material, sj-docx-3-opp-10.1177_10781552231160275 for Cost savings and cost avoidance with the inpatient clinical pharmacist interventions in a tertiary cancer care hospital by Dina Abushanab, Amaal Gulied, Anas Hamad, Mohammad Abu-Tineh, Palli V Abdul Rouf, Moza Al Hail, Wessam El-Kassem, Maguy S El Hajj and Daoud Al-Badriyeh in Journal of Oncology Pharmacy Practice

Predictive value of tyrosine phosphatase receptor gamma for the response to treatment tyrosine kinase inhibitors in chronic myeloid leukemia patients

Mohamed A. Ismail, Marzia Vezzalini, Hisham Morsi, Ahmad Abujaber, Ali Al Sayab, Kodappully Siveen, Mohamed A. Yassin, Maria Monne, Muthanna Samara, Richard Cook, Claudio Sorio, Helmout Modjtahedi & Nader I. Al-Dewik
Protein tyrosine phosphatase receptor gamma (PTPRG) is a member of the receptor-like family protein tyrosine phosphatases and acts as a tumor suppressor gene in different neoplasms. Recent studies reported the down-regulation of PTPRG expression levels in Chronic Myeloid Leukemia disease (CML). In addition, the BCR-ABL1 transcript level is currently a key predictive biomarker of CML response to treatment with Tyrosine Kinase Inhibitors (TKIs). The aim of this study was to employ flow cytometry to monitor...

sj-docx-1-opp-10.1177_10781552231160275 - Supplemental material for Cost savings and cost avoidance with the inpatient clinical pharmacist interventions in a tertiary cancer care hospital

Dina Abushanab, Amaal Gulied, Anas Hamad, Mohammad Abu-Tineh, Palli V Abdul Rouf, Moza Al Hail, Wessam El-Kassem, Maguy S El Hajj & Daoud Al-Badriyeh
Supplemental material, sj-docx-1-opp-10.1177_10781552231160275 for Cost savings and cost avoidance with the inpatient clinical pharmacist interventions in a tertiary cancer care hospital by Dina Abushanab, Amaal Gulied, Anas Hamad, Mohammad Abu-Tineh, Palli V Abdul Rouf, Moza Al Hail, Wessam El-Kassem, Maguy S El Hajj and Daoud Al-Badriyeh in Journal of Oncology Pharmacy Practice

Insulin sensitivity variations in apparently healthy Arab male subjects: correlation with insulin and C peptide

Noor Suleiman, Meis Alkasem, Shaimaa Hassoun, Ibrahem Abdalhakam, Ilham Bettahi, Fayaz Mir, Manjunath Ramanjaneya, Jayakumar Jerobin, Ahmad Iskandarani, Tareq A. Samra, Prem Chandra, Monica Skarulis & Abdul Badi Abou-Samra
Introduction Decreased insulin sensitivity occurs early in type 2 diabetes (T2D). T2D is highly prevalent in the Middle East and North Africa regions. This study assessed the variations in insulin sensitivity in normal apparently healthy subjects and the levels of adiponectin, adipsin and inflammatory markers. Research design and methods A total of 60 participants (aged 18–45, body mass index <28) with a normal oral glucose tolerance test (OGTT) completed hyperinsulinemic-euglycemic clamp (40 mU/m2/min) and body...

The impact of enteric coating of aspirin on aspirin responsiveness in patients with suspected or newly diagnosed ischemic stroke: prospective cohort study: results from the (ECASIS) study

Mohamed Nabil Elshafei, Yahia Imam, Arwa Ebrahim Alsaud, Prem Chandra, Aijaz Parray, Mohamed S. Abdelmoneim, Khaldun Obeidat, Razan Saeid, Mohammad Ali, Raheem Ayadathil, Mouhand F. H. Mohamed, Ibtihal M. Abdallah, Shaban Mohammed, Naveed Akhtar & Mohammed Ibn-Masoud Danjuma
Background and purpose Uncertainty remains regarding the impact of enteric-coated aspirin (EC-ASA) on secondary prevention of ischemic stroke compared to plain aspirin (P-ASA). Hence, this study was designed to investigate the effect of EC formulation on ASA response via evaluating thromboxane B2 (TXB2) levels in patients with suspected or newly diagnosed stroke. Methods A prospective cohort study on suspected or newly diagnosed ischemic stroke patients who are aspirin-naive was conducted. Patients were received either EC...

Tuberculosis following programmed cell death receptor-1 (PD-1) inhibitor in a patient with non-small cell lung cancer. Case report and literature review

Aasir M. Suliman, Shaza A. Bek, Mohamed S. Elkhatim, Ahmed A. Husain, Ahmad Y. Mismar, M. Z. Sharaf Eldean, Zsolt Lengyel, Shereen Elazzazy, Kakil I. Rasul & Nabil E. Omar
Immune checkpoint inhibitors (ICIs)—anti-programmed death-1 (PD-1) and their ligands (PD-L1 and PD-L2) have become widely used in the treatment of several malignancies. Many immune-related adverse events (irAEs) have been linked to these agents. Nonetheless, tuberculosis (TB) reactivation during their use is increasingly recognized and reported. Herein, we present a 58-year-old lady with advanced non-small cell lung cancer (NSCLC) ALK-negative, EGFR wild, and PD-L1 immune histochemistry (IHC) strongly positive in 95% of tumor cells, on ongoing...

sj-docx-5-opp-10.1177_10781552231160275 - Supplemental material for Cost savings and cost avoidance with the inpatient clinical pharmacist interventions in a tertiary cancer care hospital

Dina Abushanab, Amaal Gulied, Anas Hamad, Mohammad Abu-Tineh, Palli V Abdul Rouf, Moza Al Hail, Wessam El-Kassem, Maguy S El Hajj & Daoud Al-Badriyeh
Supplemental material, sj-docx-5-opp-10.1177_10781552231160275 for Cost savings and cost avoidance with the inpatient clinical pharmacist interventions in a tertiary cancer care hospital by Dina Abushanab, Amaal Gulied, Anas Hamad, Mohammad Abu-Tineh, Palli V Abdul Rouf, Moza Al Hail, Wessam El-Kassem, Maguy S El Hajj and Daoud Al-Badriyeh in Journal of Oncology Pharmacy Practice

The impact of enteric coating of aspirin on aspirin responsiveness in patients with suspected or newly diagnosed ischemic stroke: prospective cohort study: results from the (ECASIS) study

Mohamed Nabil Elshafei, Yahia Imam, Arwa Ebrahim Alsaud, Prem Chandra, Aijaz Parray, Mohamed S. Abdelmoneim, Khaldun Obeidat, Razan Saeid, Mohammad Ali, Raheem Ayadathil, Mouhand F. H. Mohamed, Ibtihal M. Abdallah, Shaban Mohammed, Naveed Akhtar & Mohammed Ibn-Masoud Danjuma
Background and purpose Uncertainty remains regarding the impact of enteric-coated aspirin (EC-ASA) on secondary prevention of ischemic stroke compared to plain aspirin (P-ASA). Hence, this study was designed to investigate the effect of EC formulation on ASA response via evaluating thromboxane B2 (TXB2) levels in patients with suspected or newly diagnosed stroke. Methods A prospective cohort study on suspected or newly diagnosed ischemic stroke patients who are aspirin-naive was conducted. Patients were received either EC...

Tuberculosis following programmed cell death receptor-1 (PD-1) inhibitor in a patient with non-small cell lung cancer. Case report and literature review

Aasir M. Suliman, Shaza A. Bek, Mohamed S. Elkhatim, Ahmed A. Husain, Ahmad Y. Mismar, M. Z. Sharaf Eldean, Zsolt Lengyel, Shereen Elazzazy, Kakil I. Rasul & Nabil E. Omar
Immune checkpoint inhibitors (ICIs)—anti-programmed death-1 (PD-1) and their ligands (PD-L1 and PD-L2) have become widely used in the treatment of several malignancies. Many immune-related adverse events (irAEs) have been linked to these agents. Nonetheless, tuberculosis (TB) reactivation during their use is increasingly recognized and reported. Herein, we present a 58-year-old lady with advanced non-small cell lung cancer (NSCLC) ALK-negative, EGFR wild, and PD-L1 immune histochemistry (IHC) strongly positive in 95% of tumor cells, on ongoing...

Additional file 1 of Successful breastfeeding following a level II NICU stay in Qatar – a longitudinal study

Brijroy Viswanathan, Rajai El Bedaywi, Ahmed Tomerak, Sarfrazul Abedin & Prem Chandra
Additional file 1. Lactation chart.

Additional file 1 of Successful breastfeeding following a level II NICU stay in Qatar – a longitudinal study

Brijroy Viswanathan, Rajai El Bedaywi, Ahmed Tomerak, Sarfrazul Abedin & Prem Chandra
Additional file 1. Lactation chart.

Successful breastfeeding following a level II NICU stay in Qatar – a longitudinal study

Brijroy Viswanathan, Rajai El Bedaywi, Ahmed Tomerak, Sarfrazul Abedin & Prem Chandra
Abstract Background Exclusive breastfeeding is an essential need for mothers and newborn babies, but cultural practices and employment demands significantly influence feeding practices. The association between neonatal intensive care unit (NICU) admission and breastfeeding outcomes are variable. Data for Qatar and Middle East, in particular, are limited. Hence, this study aims to estimate the rate of breastfeeding at the time of NICU discharge and the rate of successful breastfeeding after NICU discharge in Qatar during...

The Epidemiology of Cystic Fibrosis in Arab Countries: A Systematic Review

Samer Hammoudeh, Wessam Gadelhaq, Yahya Hani, Nadia Omar, Darine El Dimassi, Cynthia Elizabeth, Abdul Kareem Pullattayil, Prem Chandra & Ibrahim A. Janahi
Cystic fibrosis (CF) is a genetic autosomal recessive disease that involves multiple systems. Both life quality and expectation are affected by the debilitating multi-system involvement of the disease which includes pulmonary, gastrointestinal, reproductive, and endocrine symptoms. Very few studies have covered the epidemiological aspects of the disease among Arab countries. To systematically review the available epidemiological literature on cystic fibrosis in order to describe the epidemiological state of this disease in the Arab world, this...

Clinical utility of ANA-ELISA vs ANA-immunofluorescence in connective tissue diseases

Omar Suhail Alsaed, Laith Ishaq Alamlih, Omar Al-Radideh, Prem Chandra, Samar Alemadi & Abdul-Wahab Al-Allaf
We investigated the performance of ANA-ELISA for CTDs screening and diagnosis and comparing it to the conventional ANA-IIF. ANA-ELISA is a solid-phase immune assay includes 17 ANA-targeted recombinant antigens; dsDNA, Sm-D, Rib-P, PCNA, U1-RNP (70, A, C), SS-A/Ro (52 and 60), SS-B/La, Centromere B, Scl-70, Fibrillarin, RNA Polymerase III, Jo-1, Mi-2, and PM-Scl. During the period between March till December 2016 all requests for ANA from primary, secondary, and tertiary care centers were processed with...

sj-docx-1-opp-10.1177_10781552231160275 - Supplemental material for Cost savings and cost avoidance with the inpatient clinical pharmacist interventions in a tertiary cancer care hospital

Dina Abushanab, Amaal Gulied, Anas Hamad, Mohammad Abu-Tineh, Palli V Abdul Rouf, Moza Al Hail, Wessam El-Kassem, Maguy S El Hajj & Daoud Al-Badriyeh
Supplemental material, sj-docx-1-opp-10.1177_10781552231160275 for Cost savings and cost avoidance with the inpatient clinical pharmacist interventions in a tertiary cancer care hospital by Dina Abushanab, Amaal Gulied, Anas Hamad, Mohammad Abu-Tineh, Palli V Abdul Rouf, Moza Al Hail, Wessam El-Kassem, Maguy S El Hajj and Daoud Al-Badriyeh in Journal of Oncology Pharmacy Practice

sj-docx-4-opp-10.1177_10781552231160275 - Supplemental material for Cost savings and cost avoidance with the inpatient clinical pharmacist interventions in a tertiary cancer care hospital

Dina Abushanab, Amaal Gulied, Anas Hamad, Mohammad Abu-Tineh, Palli V Abdul Rouf, Moza Al Hail, Wessam El-Kassem, Maguy S El Hajj & Daoud Al-Badriyeh
Supplemental material, sj-docx-4-opp-10.1177_10781552231160275 for Cost savings and cost avoidance with the inpatient clinical pharmacist interventions in a tertiary cancer care hospital by Dina Abushanab, Amaal Gulied, Anas Hamad, Mohammad Abu-Tineh, Palli V Abdul Rouf, Moza Al Hail, Wessam El-Kassem, Maguy S El Hajj and Daoud Al-Badriyeh in Journal of Oncology Pharmacy Practice

Cost savings and cost avoidance with the inpatient clinical pharmacist interventions in a tertiary cancer care hospital

Dina Abushanab, Amaal Gulied, Anas Hamad, Mohammad Abu-Tineh, Palli V Abdul Rouf, Moza Al Hail, Wessam El-Kassem, Maguy S El Hajj & Daoud Al-Badriyeh
BackgroundThe economic benefit of the clinical pharmacist's role in ensuring the optimum use of medicines is potentially considerable, particularly when it comes to cancer management. We sought to evaluate the overall economic impact of clinical pharmacist interventions in the main cancer setting in Qatar.MethodsThe total economic benefit of the clinical pharmacy interventions were analyzed from the public hospital perspective. Patient records in March 2018, July/August 2018, and January 2019 were retrospectively reviewed at the National...

Successful breastfeeding following a level II NICU stay in Qatar – a longitudinal study

Brijroy Viswanathan, Rajai El Bedaywi, Ahmed Tomerak, Sarfrazul Abedin & Prem Chandra
Abstract Background Exclusive breastfeeding is an essential need for mothers and newborn babies, but cultural practices and employment demands significantly influence feeding practices. The association between neonatal intensive care unit (NICU) admission and breastfeeding outcomes are variable. Data for Qatar and Middle East, in particular, are limited. Hence, this study aims to estimate the rate of breastfeeding at the time of NICU discharge and the rate of successful breastfeeding after NICU discharge in Qatar during...

Manifestations of HbSE sickle cell disease: a systematic review

Ibrahim Khamees, Fateen Ata, Hassan Choudry, Ashraf T. Soliman, Vincenzo De Sanctis & Mohamed A. Yassin
Background Sickle cell disease (SCD) is commonly encountered in Africa and Middle Eastern countries. The causative mutation in the gene encoding the hemoglobin subunit β (HBB) leads to various genotypic variants of the disease. This results in varied phenotypes, with a spectrum of complications, from benign to fatal. Hemoglobin SS (HBSS) genotype is associated with most of these complications; hence, it is a severe form of SCD. On the other hand, rare genotypes such as...

Manifestations of HbSE sickle cell disease: a systematic review

Ibrahim Khamees, Fateen Ata, Hassan Choudry, Ashraf T. Soliman, Vincenzo De Sanctis & Mohamed A. Yassin
Background Sickle cell disease (SCD) is commonly encountered in Africa and Middle Eastern countries. The causative mutation in the gene encoding the hemoglobin subunit β (HBB) leads to various genotypic variants of the disease. This results in varied phenotypes, with a spectrum of complications, from benign to fatal. Hemoglobin SS (HBSS) genotype is associated with most of these complications; hence, it is a severe form of SCD. On the other hand, rare genotypes such as...

Insulin sensitivity variations in apparently healthy Arab male subjects: correlation with insulin and C peptide

Noor Suleiman, Meis Alkasem, Shaimaa Hassoun, Ibrahem Abdalhakam, Ilham Bettahi, Fayaz Mir, Manjunath Ramanjaneya, Jayakumar Jerobin, Ahmad Iskandarani, Tareq A. Samra, Prem Chandra, Monica Skarulis & Abdul Badi Abou-Samra
Introduction Decreased insulin sensitivity occurs early in type 2 diabetes (T2D). T2D is highly prevalent in the Middle East and North Africa regions. This study assessed the variations in insulin sensitivity in normal apparently healthy subjects and the levels of adiponectin, adipsin and inflammatory markers. Research design and methods A total of 60 participants (aged 18–45, body mass index <28) with a normal oral glucose tolerance test (OGTT) completed hyperinsulinemic-euglycemic clamp (40 mU/m2/min) and body...

sj-docx-4-opp-10.1177_10781552231160275 - Supplemental material for Cost savings and cost avoidance with the inpatient clinical pharmacist interventions in a tertiary cancer care hospital

Dina Abushanab, Amaal Gulied, Anas Hamad, Mohammad Abu-Tineh, Palli V Abdul Rouf, Moza Al Hail, Wessam El-Kassem, Maguy S El Hajj & Daoud Al-Badriyeh
Supplemental material, sj-docx-4-opp-10.1177_10781552231160275 for Cost savings and cost avoidance with the inpatient clinical pharmacist interventions in a tertiary cancer care hospital by Dina Abushanab, Amaal Gulied, Anas Hamad, Mohammad Abu-Tineh, Palli V Abdul Rouf, Moza Al Hail, Wessam El-Kassem, Maguy S El Hajj and Daoud Al-Badriyeh in Journal of Oncology Pharmacy Practice

Registration Year

  • 2023
    26
  • 2022
    6

Resource Types

  • Text
    28
  • Collection
    4

Affiliations

  • National Center for Cancer Care and Research
    32
  • Hamad Medical Corporation
    26
  • Qatar University
    12
  • University of Waterloo
    2
  • University of Leeds
    2
  • Birkbeck, University of London
    2
  • Indonesia University of Education
    2
  • University of York
    2
  • University of Oxford
    2
  • Kingston University
    2